Ramanathan, R. K., Goldstein, D., Korn, R. L., Arena, F. P., Moore, M., Siena, S., . . . Von Hoff, D. D. (2016). Positron emission tomography response evaluation from a randomized phase III trial of weekly nab -paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Ramanathan, R. K., et al. Positron Emission Tomography Response Evaluation from a Randomized Phase III Trial of Weekly Nab -paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for Patients with Metastatic Adenocarcinoma of the Pancreas. 2016.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Ramanathan, R. K., et al. Positron Emission Tomography Response Evaluation from a Randomized Phase III Trial of Weekly Nab -paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for Patients with Metastatic Adenocarcinoma of the Pancreas. 2016.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.